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Monoallelic exclusion ensures that the African trypanosome
Trypanosoma brucei exclusively expresses only 1 of thousands of
different variant surface glycoprotein (VSG) coat genes. The active
VSG is transcribed from 1 of 15 polycistronic bloodstream-form
VSG expression sites (ESs), which are controlled in a mutually ex-
clusive fashion. Unusually, T. brucei uses RNA polymerase I (Pol I)
to transcribe the active ES, which is unprecedented among eukary-
otes. This active ES is located within a unique extranucleolar Pol I
body called the expression-site body (ESB). A stringent restriction
mechanism prevents T. brucei from expressing multiple ESs at the
same time, although how this is mediated is unclear. By using
drug-selection pressure, we generated VSG double-expresser T.
brucei lines, which have disrupted monoallelic exclusion, and si-
multaneously express 2 ESs in a dynamic fashion. The 2 unstably
active ESs appear epigenetically similar to fully active ESs as de-
termined by using chromatin immunoprecipitation for multiple
epigenetic marks (histones H3 and H1, TDP1, and DNA base J).
We find that the double-expresser cells, similar to wild-type
single-expresser cells, predominantly contain 1 subnuclear ESB,
as determined using Pol I or the ESB marker VEX1. Strikingly, si-
multaneous transcription of the 2 dynamically transcribed ESs is
normally observed only when the 2 ESs are both located within
this single ESB. This colocalization is reversible in the absence of
drug selection. This discovery that simultaneously active ESs dy-
namically share a single ESB demonstrates the importance of this
unique subnuclear body in restricting the monoallelic expression
of VSG.
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The monoallelic expression of 1 gene out of a large assortmentof highly similar variants is a poorly understood phenome-
non. The olfactory receptors are the most widely studied exam-
ple of monoallelic exclusion in mammals, whereby each sensory
neuron within the nose expresses 1 odorant receptor gene out of
a repertoire of more than 1,400 genes (1, 2). The stochastic but
irreversible activation of individual olfactory receptor (OR)
genes during development of the olfactory epithelium relies on a
3-node signaling cascade, which locks down the epigenetic state
of the chosen OR gene and stabilizes its expression (3, 4). Nu-
clear architecture plays a key role in the regulation of the OR
genes. These form interchromosomal contacts, which result in
them clustering in subnuclear OR gene compartments and thereby
facilitating monoallelic exclusion (5). Monoallelic exclusion is also
vital for parasites controlling expression of multiple similar variant
antigen genes. The malaria parasite Plasmodium falciparum strictly
controls expression of 1 of many var genes. Here, nuclear locali-
zation also plays a key role, along with other epigenetic mecha-
nisms, including histone modifications and noncoding RNAs (6).
Survival of the African trypanosome Trypanosoma brucei relies
on monoallelic expression of 1 of thousands of variant surface
glycoprotein (VSG) genes. T. brucei is a unicellular parasite of
the mammalian bloodstream, causing diseases including African
sleeping sickness (7). Bloodstream-form T. brucei is protected by
a dense coat of a single type of VSG (8–10). To ensure that
antigenic variation operates properly, it is key that only 1 VSG is
expressed at a time in each trypanosome. The active VSG is lo-
cated in 1 of ∼15 polycistronic telomeric bloodstream-form VSG
expression site (BES or ES) transcription units (11). Switching the
active VSG can involve DNA rearrangements or transcriptional
control, as the trypanosome switches between different ESs (12–
14). Numerous epigenetic factors including chromatin proteins
and remodelers have been identified, which ensure that a partic-
ular ES activation state is maintained (14–18). However, very little
is known about how ESs are rigorously counted in such a stringent
fashion.
Unusually, the protein-coding genes within the T. brucei
ESs are transcribed by RNA polymerase I (Pol I), which is un-
precedented among eukaryotes (19, 20). Typically, Pol I exclu-
sively transcribes ribosomal DNA (rDNA) in a subnuclear Pol I
body known as the nucleolus (21). However, in addition to the
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nucleolus, there is a unique nonnucleolar Pol I body in T. brucei
known as the expression-site body (ESB), which contains the active
ES (22, 23). Very little is known about the architecture of the ESB.
The VEX1 protein has been identified as uniquely locating to the
ESB, but its exact function is still unclear (24). In other organisms
that use monoallelic exclusion, nuclear architecture plays a role in
controlling the activation and silencing of allelic loci (5, 25).
However, in T. brucei, the influence of nuclear positioning on the
monoallelic exclusion of the ESs is still poorly understood (17).
To better understand the restrictions operating on monoallelic
exclusion, we generated trypanosome cell lines in which this was
disrupted. Although bloodstream-form T. brucei expresses only
a single ES at a time, perturbation of ES monoallelic exclusion
can be achieved by using drug-selection pressure (26, 27). We
used this approach to generate independently derived T.
brucei double-expresser strains that unstably and transiently ex-
press 2 ESs at the same time. These unstably transcriptionally
active ESs appear to have an epigenetic state similar to that of
fully active ESs. We find that the 2 ESs are in closer proximity
to each other when they are dynamically transcribed in double-
expresser T. brucei compared with when only 1 ES is active in
single-expressers. The double-expresser T. brucei typically have a
single ESB, similar to single-expressers. Strikingly, we see simul-
taneous transcription of 2 ESs only when these are colocalized
within a single ESB. These results showing that the 2 dynamically
transcribed ESs appear to continuously transition between a single
shared ESB demonstrate the importance of this unique subnuclear
body in restricting the monoallelic expression of VSG.
Results
To select for simultaneous activation of 2 ESs, we generated T.
brucei strains with drug resistance genes inserted into the telo-
meric regions of BES1 and BES2 (11). We first inserted the
eGFP and puromycin/thymidine kinase (TK) genes immediately
upstream of VSG221 in BES1 (Fig. 1A) (11). Using TK as a
negative selectable marker, we subsequently generated VSG switch
variants, of which 1 had activated BES2 (11). We next inserted the
hygromycin resistance and mCherry genes upstream of VSGV02 in
BES2 to generate the VSGV02-expressing (V02+)PG-VHC line
(Fig. 1A). Selection for reactivation of BES1 resulted in genera-
tion of the VSG221-expressing (221+)PG-VHC line.
Both parental lines were subjected to drug-selection pressure
to select for simultaneous activation of both BES1 and BES2.
We used concentrations of selection drugs that are higher than
standard concentrations to increase the stringency of selection,
as this did not have a deleterious effect on growth (SI Appendix,
Fig. S1 A and B). We generated the double-expresser DE
KW01 line from the BES1-expressing (221+)PG-VHC parental
line, and the DE BH03 line from the BES2-expressing (V02+)
PG-VHC line (Fig. 1A). Frequency of generation of double-
expresser (DE) lines was very low (<10−8). The growth rate of
the DE KW01 line was equivalent to the parental line, whereas
the DE BH03 line appeared to show a minor reduction in growth
rate (SI Appendix, Fig. S1C).
To confirm that both marked ESs in the double-expresser cells
were active, we used flow cytometry to monitor ES activation
state. As expected, the parental (221+)PG-VHC line expressed
GFP, and the (V02+)PG-VHC line expressed mCherry (Fig.
1B). In contrast, the double-expresser DE KW01 and DE BH03
cell lines expressed both fluorescent proteins at the same time
(Fig. 1B), and expression of a fluorescent protein gene within a
given ES corresponded with expression of the respective VSG
(SI Appendix, Figs. S2–S4). Both double-expresser lines expressed
approximately equivalent levels of VSG221 and VSGV02, each
at approximately half of normal VSG levels, as monitored by
Western blot analysis (SI Appendix, Fig. S2). As expected, both
VSG221 and VSGV02 appeared to show normal cellular local-
ization (SI Appendix, Fig. S3).
The 2 parental (221+)PG-VHC and (V02+)PG-VHC lines
expressed the relevant active ES even in the absence of drug-
selection pressure for 96 h (SI Appendix, Fig. S5). Only a minor
fraction of trypanosomes were nonfluorescent, possibly as a con-
sequence of a switch to another ES not containing a fluorescent
protein gene. However, removal of the double-expresser DE KW01
and DE BH03 strains from drug-selection pressure resulted in
a process of relapse back to single expression of either BES1 or
BES2 with strain-dependent kinetics (Fig. 2). The DE BH03
strain reverted back to single-expression relatively quickly
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Fig. 1. Selection for simultaneous activation of 2 VSG expression sites re-
sults in the generation of T. brucei double-expresser (DE) cell lines. (A) The
schematics indicate the parental cell line (221+)PG-VHC VSG221 with an
active VSG221 expression site (BES1) and the (V02+)PG-VHC line with an
active VSGV02 expression site (BES2). In both cell lines, the puromycin/thy-
midine kinase fusion (Pur/TK) and GFP genes are inserted upstream of
VSG221 in BES1, and the hygromycin resistance (Hyg) and mCherry genes are
inserted upstream of VSGV02 in BES2. The double-expresser (DE) DE
KW01 cell line was generated by using drug selection for activation of both
ESs using the (221+)PG-VHC strain, and the DE BH03 line was generated by
using the same approach with the parental (V02+)PG-VHC line (large open
arrows). The ES promoters are indicated with flags, transcription with ar-
rows, characteristic 70-bp repeats with hatched boxes, and the relevant
genes with colored boxes. Dynamic ES transcription is indicated with arrows
with dashed lines. (B) Double-expression of VSG expression sites monitored
by flow cytometry. Traces show quantitation of GFP expressed from BES1 on
the y axis and mCherry expressed from BES2 on the x-axis. (Top) Non-
fluorescent wild type (WT) VSG221 (221+)-expressing strain compared with
the VSG221 and VSGV02 expressing parental lines (221+)PG-VHC or (V02+)
PG-VHC. (Bottom) Traces from the 2 double-expresser lines DE KW01 and
BH03, which express both BES1 and BES2 at the same time (221+ & VO2+).
Gates are shown as 98th percentile relative to the control.
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compared with the DE KW01 strain, which was more stable.
Possibly, these strains have acquired different genetic muta-
tions, which impact their ability to establish a double-expresser
state. Both double-expresser lines started to revert back to either
BES1 or BES2 in a relatively unbiased manner, irrespective of
the ES expressed by the original parental line from which the
double-expresser was derived.
We did not see significant numbers of nonfluorescent try-
panosomes even after 96 h off drug selection (gate Q4; Fig. 2).
This indicates that the trypanosomes switched back to either
BES1 or BES2, rather than activating 1 of the 13 silent ESs. This
implies that the epigenetic state of the unstably transcriptionally
active ESs in double-expresser cells can be heritably transmitted
over many days rather than being rapidly erased. The extent of
these putative epigenetic modifications appeared to be sufficient to
enable the rapid and full reactivation of the 2 unstably active ESs.
To investigate this further, we determined the distribution of
various epigenetic markers at different activation states of BES1
and BES2. The inserted fluorescence protein and drug resistance
genes served as single copy sequences in addition to the VSG
genes, allowing the unambiguous differentiation of BES1 and
BES2 from the 13 other highly similar ESs in T. brucei 427 (11).
When transcriptionally active, the Pol I transcribed ESs are
unusually depleted of histones (28–30), which is characteristic of
actively transcribed Pol I transcription units in general (31, 32).
By using chromatin immunoprecipitation (ChIP) of the core
histone H3, we established that, as expected, the parental (221+)
PG-VHC and (V02+)PG-VHC cell lines showed greatly reduced
levels of histone H3 on the 1 fully active ES compared with a
silent ES (Fig. 3 A and B). In contrast, the double-expresser DE
KW01 line showed depleted levels of histone H3 on both the
unstably active BES1 and BES2. These levels were comparable
with those on fully active ESs (Fig. 3C). These ChIP results were
particularly clear when single copy genes were analyzed (eGFP
P < 0.01, mCherry P < 0.05). However, in the case of VSGV02, a
second silent copy of the VSGV02 gene not located within BES2
could also have given rise to the ChIP signal. The same relative
histone depletion on active ESs was observed in ChIP experiments
detecting the linker histone H1 (SI Appendix, Fig. S6) (30).
An additional epigenetic mark distinguishing ESs according to
activation state is the glucosylated DNA nucleotide base J (33).
Base J is enriched at the telomeres of the silent ESs, with the
concentration of base J increasing in a gradient extending toward
the telomere end (34). By using an antibody against base J (34)
in ChIP-seq experiments (35), we found that levels of base
J-containing DNA indeed increased in a gradient extending to-
ward the telomere of a silent ES in the single-expresser lines
(Fig. 3 D and E). In contrast, base J levels were very low in the
active ES (Fig. 3 D and E). In the double-expresser DE KW01
line, base J levels were highly reduced at the unstably active BES1
and BES2, comparable to an active ES (eGFP P < 0.01, VSG221
P < 0.0001; Fig. 3F). The architectural chromatin protein TDP1,
in contrast to histones and base J, is enriched on active ESs and
depleted on silent ESs (36, 37). Here too, TDP1 distribution over
the unstably active BES1 and BES2 appeared to be comparable to
that observed on fully active ESs (SI Appendix, Fig. S7). Although
the results of the TDP ChIP were not statistically significant, they
indicate a trend. All of these data are compatible with the unstably
active BES1 and BES2 having the epigenetic marks and chromatin
state of fully active ESs. This active chromatin state possibly fa-
cilitates the rapid switching between the 2 selected ESs, thereby
enabling the double-expresser phenotype.
We next investigated the subnuclear location of BES1 and
BES2 in the double-expresser DE KW01 strain compared with
its single-expresser parent (221+)PG-VHC using structured il-
lumination superresolution microscopy (SIM-SR). As these cell
lines fluoresce red and green, we first inserted an inducible RNAi
construct targeting both eGFP and mCherry into these lines (Fig.
4A). After inducing fluorescent protein (FP) RNAi for 72 h, the
resulting cell lines were not fluorescent. This allowed us to per-
form DNA fluorescence in situ hybridization (FISH) experiments
using probes specific for either BES1 or BES2.
In the parental (221+)PG-VHC FP-RNAi cells, only BES1 is
transcriptionally active. DNA probes specific for either BES1 or
BES2 allowed identification of these ESs by FISH (Fig. 4B). BES1
and BES2 were normally not in close proximity to each other (Fig.
4C), and were relatively randomly distributed within the nucleus,
with an average distance of 1.1 ± 0.49 μm (Fig. 4D). In contrast, in
the double-expresser DE KW01 FP-RNAi cells in which both
BES1 and BES2 are unstably transcriptionally active, BES1 and
BES2 were in significantly closer proximity to each other. They
were separated with an average distance of 0.5 ± 0.38 μm (P <
0.0001), with 25% located within 200 nm of each other (Fig. 4D).
This preferential colocalization of BES1 and BES2 in the
double-expresser DE KW01 strain was reversible in the absence
of double drug selection. If double-expresser DE KW01 cells
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were removed from drug selection for 120 h, the average dis-
tance between BES1 and BES2 increased significantly from
0.45 ± 0.38 μm to 0.89 ± 0.6 μm (P < 0.0015; Fig. 4E). This
average distance between BES1 and BES2 is comparable to that
observed in the single-expresser (221+)PG-VHC line. This ob-
servation that BES1 and BES2 moved apart from each other in
the absence of drug selection was coincident with reversion of
the cells back to a single-expresser state, as was shown earlier by
using flow cytometry (Fig. 2A).
We next performed Stellaris RNA FISH to determine where
transcription of the 2 unstably active ESs was occurring. In-
duction of RNAi against the fluorescent proteins resulted in the
cell lines becoming nonfluorescent so that RNA FISH could be
performed. BES1 transcription was then detected with a probe
for a single copy VSG pseudogene (VSGΨ), which is transcribed
into an unstable nuclear RNA transcript. To detect BES2 tran-
scription, a construct containing 24 MS2 repeats was inserted
into the BES2 telomere in the single-expresser (V02+)PG-VHC
and double-expresser DE KW01 FP-RNAi strains (Fig. 5A). The
MS2-containing sequences are also transcribed into an unstable
nuclear RNA that can be detected by RNA FISH.
As expected for probes detecting unstable ES RNA tran-
scripts, RNA signal was detected exclusively in the nucleus by
Pu
ro
eG
FP
VS
G 
22
1
Hy
gr
o
m
Ch
er
ry
VS
G 
V0
2
VS
G 
80
0
VS
G 
14
Ac
n
Y-
Tu
bu
lin
rD
N
A 
sp
rD
N
A 
pr
o
18
S
28
S 
al
ph
a
Histone…
Pu
ro
eG
FP
VS
G 
22
1
Hy
gr
o
m
Ch
er
ry
VS
G 
V0
2
VS
G 
80
0
VS
G 
14
Ac
n
Y-
Tu
bu
lin
rD
N
A 
sp
rD
N
A 
pr
o
18
S
28
S 
al
ph
a
Histone…
Pu
ro
eG
FP
VS
G 
22
1
Hy
gr
o
m
Ch
er
ry
VS
G 
V0
2
VS
G 
80
0
VS
G 
14
Ac
n
Y-
Tu
bu
lin
rD
N
A 
sp
rD
N
A 
pr
o
18
S
28
S 
al
ph
a
Histone…
Histone H3
18
S
eG
FP
Pu
ro
VS
G
22
1
m
C
he
rr
y
H
yg
ro
VS
G
V0
2
VS
G
80
0
VS
G
14
ac
tin
tu
bu
lin
sp
ac
er
pr
om
ot
er
28
S 
α
Unstably active 
BES1 + BES2
Silent 
VSGs
Pol II rDNA
Histone H3
%
 IP
1
2
3
0
4
5
Histone H3
Silent
BES1
Active 
BES2
Silent 
VSGs
Pol II rDNA
eG
FP
Pu
ro
VS
G
22
1
m
C
he
rr
y
H
yg
ro
VS
G
V0
2
VS
G
80
0
VS
G
14
ac
tin
tu
bu
lin
sp
ac
er
pr
om
ot
er
18
S
28
S 
α
%
 IP
1
2
3
0
4
5
%
 IP
1
2
3
0
4
5
DE KW01
(221+) PG-VHC
(V02+) PG-VHC
Active 
BES1
Silent 
BES2
Silent 
VSGs
Pol II rDNA
eG
FP
Pu
ro
VS
G
22
1
m
C
he
rr
y
H
yg
ro
VS
G
V0
2
VS
G
80
0
VS
G
14
ac
tin
tu
bu
lin
sp
ac
er
pr
om
ot
er
18
S
28
S 
α
(221+) PG-VHC
100
10
1
0.1
Base J
(V02+) PG-VHC
DE KW01
VS
G
Ψ
pu
rT
K
eG
FP
VS
G
22
1
hy
gr
o
m
C
he
rr
y
VS
G
V0
2
VS
G
80
0
VS
G
14
tu
bu
lin
ac
tin
Po
l I
sp
ac
er
pr
om
ot
er
18
S
28
Sα
Silent 
BES2
Active 
BES1
Pol II rDNASilent 
VSGs
100
10
1
0.1
Base J
VS
G
Ψ
pu
rT
K
eG
FP
VS
G
22
1
hy
gr
o
m
C
he
rr
y
VS
G
V0
2
VS
G
80
0
VS
G
14
tu
bu
lin
ac
tin
Po
l I
sp
ac
er
pr
om
ot
er
18
S
28
Sα
Active
BES2
Silent
BES1
Pol II rDNASilent 
VSGs
0.1
100
10
1
Base J
pu
rT
K
eG
FP
VS
G
22
1
hy
gr
o
m
C
he
rr
y
VS
G
V0
2
VS
G
80
0
VS
G
14
tu
bu
lin
ac
tin
Po
l I
sp
ac
er
pr
om
ot
er
18
S
28
S α
Unstably active 
BES1 + BES2
Silent 
VSGs
Pol II rDNA
VS
G
Ψ
fo
ld
fo
ld
fo
ld
A
B
C
D
E
F
Fig. 3. The unstably active ESs in the double-expresser DE KW01 strain have
similar epigenetic features to the active ES in the parental single-expresser
lines. The genes analyzed are indicated below, and include loci in the Pol I
transcribed ESs and rDNA compared with Pol II transcription units. Data from
the active ESs are indicated with red boxes and silent BESs with blue boxes.
(A–C) The distribution of histone H3 was determined by using ChIP-qPCR in
the single-expresser (221+)PG-VHC (A) or (V02+)PG-VHC (B) lines compared
with the double-expresser DE KW01 line (C). Data are shown as the per-
centage of input immunoprecipitated (% IP) after subtraction of the no-
antibody control. The mean of 3 independent ChIP-qPCR experiments is
shown, with SD indicated with error bars. (D–F) The distribution of base J
was determined by using J-IP-seq in the parental (221+)PG-VHC (D) or (V02+)
PG-VHC (E) lines compared with DE KW01 (F). Fold enrichment was calcu-
lated for each gene as the ratio of median-normalized count in the J-IP li-
brary to the corresponding pre-IP library.
A
C
Fl
uo
re
sc
en
ce
 
221 ES V02 ES Merge
Fl
uo
re
sc
en
ce
 
B
(221+)
PG-VHC
FP-RNAi
DE KW01
FP-RNAi
DE KW01
FP RNAi
FP 
RNAi Phleo
*
VSG221GFPPurTK
DNA probes
BES1
//
VSGV02CherryHyg
DNA probes
BES2
//
D
is
ta
nc
e 
B
ES
1 
to
 B
ES
2 
(μ
m
)
(221+) 
PG
N=53
DE 
KW01
N=56
p<0.0001D
P=0.0015
(221+)PG-
VHC
0 120 0 48 72 120
DE KW01
hours 
off drug
E
D
is
ta
nc
e 
B
ES
1 
to
 B
ES
2 
(μ
m
)
2.5
2.0
1.5
1.0
0.5
0.0
3.0
2.0
1.0
0.0
Fig. 4. ESs are located in closer proximity to each when there is selection for
simultaneous activation in a double-expresser strain compared with the
single-expresser parental strain. (A) The schematic shows the DE KW01 FP-
RNAi cell line, which contains the FP-RNAi construct, which allows transient
knock-down of the fluorescent proteins eGFP and mCherry. Promoters are
indicated with flags, and the tetracycline-inducible promoter indicated with
an asterisk. Relevant genes are indicated with colored boxes and unstable
transcription of BES1 and BES2 with dashed arrows. The location of the DNA-
FISH probes for BES1 are indicated with red lines and those for BES2 with
green lines. (B) Representative superresolution microscopy images of DNA
FISH performed in the single-expresser (221+)PG-VHC FP-RNAi and double-
expresser DE KW01 FP-RNAi lines after probing for BES1 (red) and BES2
(green). DNA is stained with DAPI (blue). (Scale bars, 1 μm.) (C) Quantitation
of the distance between BES1 and BES2 in the images shown in B. Fluores-
cence intensity is shown in arbitrary units. (D) Distance between BES1 and
BES2 in the single-expresser (221+)PG-VHC cell line compared with the
double-expresser DE KW01 line as determined by using DNA FISH and
superresolution microscopy. Data were collected from at least 3 biological
replicates, with the average value shown with a bar ± SD and the signifi-
cance of colocalization indicated with the P value. Total number (N) of cells
analyzed is indicated below. (E) Reversibility of BES colocalization shown
through quantitation of the distance between BES1 and BES2. DNA FISH was
performed in the (221+)PG-VHC and DE KW01 cell lines in the presence or
after the removal of drug selection for the time indicated in hours. Data
were collected at 0 h, 24 h, 48 h, 72 h, 96 h, and 120 h for both the (221+)PG-
VHC and DE KW01 cell lines; however, only some relevant time points are
shown. Data shown were obtained from 3 biological replicates by using
immunofluorescence microscopy, with at least 29 cells quantitated per time
point. The average value is indicated ± SD with the significance of re-
versibility of colocalization indicated with a P value.
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using superresolution microscopy. Transcription of BES1 was
detected in the (221+)PG-VHC strain using the VSGΨ probe, or
from BES2 in the (V02+)PG-VHC strain using the MS2 repeat
probe (Fig. 5B). However, strikingly, in cells in which simulta-
neous transcription from BES1 and BES2 was observed by using
RNA-FISH, transcripts from both BES1 and BES2 (detected
using VSGΨ or MS2 probes) colocalized within 200 nm of each
other (0.098 ± 0.085 μm) in 94% of the cells (Fig. 5C). In fact, in
the majority (72%) of DE KW01 cells with simultaneous BES1
and BES2 transcription, these transcripts were located within
100 nm of each other (Fig. 5C). In contrast, transcripts from
MS2 repeats that had been inserted into the tubulin arrays in the
Tubulin-MS2 cell line were not in close proximity to transcripts
from BES1 (0.88 ± 0.48 μm; P < 0.0001; Fig. 5C).
In agreement with the highly dynamic nature of ES tran-
scription in the double-expresser DE KW01 line, RNA FISH
experiments showed that BES1 and BES2 were not simulta-
neously transcribed in all cells (Fig. 6A). In the single-expresser
(V02+)PG or (221+)PG lines, transcript was detected for either
BES1 or BES2 in ∼62 to 65% of the cells (Fig. 6A). However, in
the double-expresser KW01 line, 30% of the cells exclusively
contained BES1 transcript (VSGΨ), 26% of the cells contained
only BES2 transcript (24× MS2), and 22% of the cells simulta-
neously contained transcript specific for both BES1 and BES2.
Transcripts were not detectable for either ES in 22% of the cells.
To obtain better insight into this dynamic ES transcription, we
determined the half-lives of both VSGΨ (BES1) and 24× MS2
repeat-containing transcripts (BES2) in DE KW01. We blocked
transsplicing by using sinefungin treatment, followed by blocking
transcription with actinomycin D (38). Visualization of both ES-
specific transcripts by microscopy showed that they had very
short half-lives of 1.63 ± 0.65 min (VSGΨ) or 1.75 ± 0.62 min
(24× MS2 repeat). Simultaneous detection of both transcripts
disappeared with a half-life of 0.90 ± 0.67 min (Fig. 6B). These
results all support a model in which there is very rapid and dy-
namic switching between transcription of BES1 and BES2 in
double-expresser DE KW01 cells. Simultaneous presence of both
BES1 and BES2 nascent transcripts within the same cell normally
occurs only if both ESs are juxtaposed within 200 nm of each other
in the same subnuclear location.
Based on these FISH data, we hypothesized that the 2 unstably
active ESs were sharing a single ESB. We therefore determined
the number of ESBs in the double-expresser DE KW01 com-
pared with the single-expresser (221+)PG-VHC strain. The ESB
can be identified by using Pol I and VEX1 as markers (22, 24).
We tagged the RPA2 subunit of Pol I with mNeonGreen (mNG)
and the VEX1 ESB marker with a 12×myc epitope in both the
single-expresser and double-expresser strains (24). In strains that
contain epitope-tagged Pol I, a small extranucleolar focus can be
seen that corresponds to the ESB (Fig. 7A, white arrowhead),
which is in addition to the nucleolus (Fig. 7A). Quantitation of
Pol I foci throughout the cell cycle showed that a similar distri-
bution is observed in both the single-expresser (221+)PG-VHC
and double-expresser DE KW01 strains, with cells predomi-
nantly containing a single ESB. Similar results were obtained if
the ESB marker VEX1 was monitored. Here also, a single VEX1-
containing ESB focus was typically seen in the cell, with a similar
distribution of VEX1 foci observed in both single-expresser and
double-expresser cells (Fig. 7B).
We next determined where simultaneous transcription of
BES1 and BES2 was occurring with relation to the ESB in the
double-expresser cells. Following RNAi-mediated knockdown of
GFP and mCherry, we performed RNA FISH visualizing BES1
transcription using a VSGΨ probe and BES2 transcription using
a probe for the 24×MS2 repeats in cells in which the RPA2 Pol I
subunit had been epitope-tagged with mNeonGreen (Fig. 7C).
When both BES1 and BES2 were simultaneously transcribed in
the double-expresser DE KW01 cells in the G1 stage of the cell
cycle, the BES1-specific transcript (VSGΨ) and the BES2-specific
transcript (24× MS2) transcript normally both colocalized within
1 extranucleolar Pol I focus (83% of cells; Fig. 7C and SI Ap-
pendix, Fig. S8A). This argues that the presence of a single Pol
I-containing ESB restricts the monoallelic expression of VSG. In
the small number of cells that had 2 Pol I foci (6.5%), most had
BES1 transcript (VSGΨ) in 1 focus and BES2 transcript (MS2)
in the other (SI Appendix, Fig. S8B). We did not observe cells
with both BES transcripts in a single Pol I focus when 2 ESBs
were present. In cells in which transcriptional signals were si-
multaneously detected from both BES1 and BES2, the individual
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Fig. 5. Simultaneous transcription of 2 unstably active ESs in the same
subnuclear location in double-expresser DE KW01 cells. (A) Schematic of the DE
KW01 MS2-V02 telo FP-RNAi cell line used for the RNA FISH experiments. This
line contains a construct with a 24×MS2 repeat cassette linked to a blasticidin
resistance gene (bla) integrated immediately upstream of the VSGV02 gene.
Stellaris RNA FISH probes are indicated, with 1 set hybridizing with the VSGΨ
in BES1 (green line) and the other set hybridizing with the MS2 repeat se-
quence in BES2 (red line). Further, the schematic is as described in Fig. 4A. (B)
Representative superresolution microscopy images of RNA FISH performed on
the single-expresser (221+)PG-VHC or (V02+)PG-VHC cell lines compared with
the double-expresser DE KW01. A cell line containing MS2 repeats in the tu-
bulin locus (Tubulin-MS2) is included as a control. Experiments using probes
against the VSGΨ (green) or the 24× MS2 repeats (red) are shown, with DNA
stained with DAPI (blue). (Scale bar, 500 nm.) (C) Quantitation of the distance
between nascent VSGΨ and MS2 repeat containing transcripts using super-
resolution microscopy. The MS2 repeats are located in BES2 in DE KW01 MS2-
V02 or in the tubulin locus (Tubulin-MS2). The average distance is shown ± SD
with the significance of colocalization indicated with a P value.
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BES signals were reduced compared with signals from cells in
which either BES1 or BES2 were transcribed individually (SI
Appendix, Fig. S8B). This argues that the ESB contains limiting
factors for ES transcription, and the restriction of ES tran-
scriptional components to a single ESB facilitates monoallelic
exclusion. Our results highlight the importance of a single ESB
structure in restricting the monoallelic expression of VSG.
Discussion
We have selected for simultaneous activation of 2 ESs in double-
expresser T. brucei strains, and show that these 2 ESs are tran-
scribed in a highly dynamic and unstable fashion (26). These
transiently transcriptionally active ESs appear to have the epi-
genetic state of fully active ESs, as monitored using epigenetic
markers including histones H3 and H1, the DNA modification
base J, and the architectural chromatin protein TDP1. Under
selection, the 2 ESs migrated within closer proximity of each
other within the nucleus. However, strikingly, simultaneous ES
transcription was normally observed only when the 2 ESs were
within 200 nm of each other. This privileged location corresponds
to the ESB subnuclear compartment, which is characterized by the
presence of Pol I and VEX1. The 2 selected ESs do not appear
able to simultaneously occupy a single ESB in a stable fashion. As
a consequence, a highly dynamic transcriptional state is generated,
as both ESs alternate back and forth between a single shared ESB
and only temporarily occupy the same ESB. These results argue
that the ESB is the key component that restricts monoallelic ex-
clusion within African trypanosomes.
The ESB is a non–membrane-bound nuclear body similar to
nucleoli and Cajal bodies (17, 39–41). Formation of both of these
cellular bodies requires RNA transcription, in a process of phase
transition-driven nuclear body assembly (22, 39–45). The for-
mation of the ESB also appears to be transcription-nucleated,
as blocking Pol I transcription by using Pol I transcriptional
DE 
KW01
(221+)
PG-VHC
RPA2
DE 
KW01
(221+)
PG-VHC
VEX1
%
 o
f n
uc
le
i
DE KW01
RPA2
1K
1N
1eK
1N
2K
1N
2K
2N
0
20
40
60
80
(221+)PG-VHC
RPA2
%
 o
f n
uc
le
i
1K
1N
1eK
1N
2K
1N
2K
2N
0
20
40
60
80 1 ESB
2 ESBs
1K
1N
1eK
1N
2K
1N
2K
2N
0
20
40
60
80
DE KW01
VEX1
1K
1N
1eK
1N
2K
1N
2K
2N
0
20
40
60
80
(221+)PG-VHC
VEX1 1 VEX1
2 VEX1
egreM2APRIPAD
DE KW01
MS2-V02
RPA2
(221+)
PG-VHC
RPA2
VSGΨ 24xMS2
A
B
C
Fig. 7. Double-expresser DE KW01 cells predominantly contain a single Pol I
and VEX1 focus, which is the location of transcription of the simultaneously
active ESs. (A) Immunofluorescence microscopy analysis of single-expresser
(221+)PG-VHC or double-expresser KW01 cells expressing the Pol I subunit
RPA2 tagged with mNeonGreen (mNG::RPA2). The extranucleolar ESB is in-
dicated with an arrowhead. The percentage (%) of nuclei containing 1 or 2
ESB foci is indicated for cells at different stages of the T. brucei cell cycle,
with the number of kinetoplasts (K), elongated kinetoplasts (eK), or nuclei
(N) indicated below. Values shown are the average ± SD of 3 biological
replicates. The number of cells counted is greater than or equal to 300, 70,
50, and 30 nuclei for the 1K1N, 1eK1N, 2K1N, or 2K2N stages, respectively.
(Scale bars: 1 μm.) (B) As in A, only the single-expresser (221+)PG-VHC or
double-expresser KW01 cells have VEX1 tagged with the 12× myc epitope.
(C) Fluorescence microscopy analysis of epitope-tagged Pol I subunit RPA2
mNG::RPA2 (green) together with RNA FISH probing for VSGΨ (magenta) or
24× MS2 repeat (red) nascent transcripts in the single-expresser (221+)PG-
VHC or double-expresser DE KW01 lines containingmNG::RPA2. DNA is stained
with DAPI, with the nucleus indicated with a dotted line and the ESB with a
white arrowhead. (Scale bars, 1 μm.)
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inhibitors results in rapid ESB disassembly, as monitored by
using Pol I and the ESB marker VEX1 (46).
If the ESB (similar to the nucleoli) is seeded by RNA, why do
2 ESBs not normally form when selection for 2 active ESs is
applied? ES transcription initiation on its own does not appear
to be sufficient for nucleation of a functional ESB. It has been
shown that, despite high levels of transcription from the active
ES, promoter-proximal ES transcripts are also generated from
multiple additional ES promoters (47, 48). However, these ES
transcripts are not polyadenylated, arguing that these partially
active ESs do not have access to efficient RNA processing (48).
The ESB structure must therefore contain both transcription and
RNA-processing machinery. If these ESB components are lim-
iting within the nucleus and naturally coalesce with each other to
self-organize into a single ESB, in a “winner-takes-all” model,
the equilibrium would favor 1 functional ESB (24). This restriction
would therefore ensure that the 2 active ESs in our double-expresser
cells would predominantly share a single ESB. This model requires
self-assembly of the ESB in a dynamic fashion.
Although most double-expresser cells contain 1 ESB, this is
not always the case. In a small subset of double-expresser cells in
G1 which simultaneously contain BES1 and BES2 transcripts, 2
ESBs (as characterized by Pol I) were present rather than 1.
However, the relative rarity of this event argues that this con-
figuration is not stable. Possibly, the trypanosome is capable of
forming 2 functional ESBs within the same cell, with each ESB
occupied by a different ES. However, the nascent transcripts
from these 2 different ESs (although not colocalizing) were in
relative proximity to each other. This argues that the second ESB
might have split off from the first rather than being in-
dependently generated. The fact that this configuration of 2
ESBs within 1 cell was found so infrequently argues that this state
may be energetically unfavorable. It has been proposed that non–
membrane-enclosed nuclear bodies naturally coalesce and self-
assemble on RNA within the nucleus in a manner similar to liq-
uid droplets, as this is energetically favorable (49, 50). This model
would explain why multiple ESBs would eventually fuse into 1.
If 2 ESBs cannot be stably formed, why do the 2 selected ESs
in double-expressers not stably occupy a single ESB? It is likely
that the ESB has a defined architecture that is optimized for high
levels of transcription and processing of transcripts from a single
ES. When 2 ESs are selected for, as both ESs appear to have the
epigenetic marks of fully active ESs, the cell cannot discriminate
which one should occupy the ESB. The 2 ESs could therefore be
in competition with each other for components of the ESB. That
competition results in a dominant ES, which temporarily hijacks
the entire structure. This process is possibly what occurs during
an in situ switch event when an invading ES is activated by taking
over the ESB.
If the cell normally only self-assembles a single stable ESB,
this makes it unclear if the presence of both BES1 and BES2
transcripts in the same ESB indeed documents simultaneous
transcription of both ESs. Instead, this could be the result of rapid
alternating transcriptional activity of the 2 ESs. The relatively
short half-lives of the nascent ES transcripts (<1 min for both
BES1 and BES2 transcripts combined) argues that the 2 ESs
might be very rapidly switching back and forth between a single
ESB compartment.
The highly dynamic nature of these ES interactions is in-
dicated by the results of the DNA FISH experiments. Although
the 2 ESs investigated are located relatively randomly (within
1.1 ± 0.49 μm of each other) in wild-type cells, this proximity is
reduced to 0.5 ± 0.38 μm in the presence of simultaneous se-
lection. However, it is only when the 2 ESs are located within
200 nm of each other within a single ESB that transcripts from
both ESs are observed in 94% of the cells. This argues that the
2 selected ESs need to be in close enough proximity to each
other to allow the invading ES to hijack ESB components from
the first ES. This appears to occur in a highly dynamic fashion
and argues that the ESs are not tethered within the nucleus.
If the ESs are not fixed to each other, statistically speaking, it
would be unlikely that more than 2 ESs interact with each other
at any one time. This is in agreement with the observation that,
in cells with 3 ESs marked with drug resistance genes, only 2 of
the 3 ESs are able to establish a rapid switching state (27). In
addition, steric hindrance could prevent more than 1 invading ES
from getting close enough to the ESB to sequester the compo-
nents. The exact positioning of the ESs within the nucleus in
relation to the ESB could therefore play a role in their relative
frequency of activation, thereby determining the preferential
hierarchy of ES activation observed earlier (51, 52).
Importantly, our ChIP analysis of epigenetic markers including
histone H3, H1, base J, and TDP1 show that it is possible to have
2 ESs in the same cell that appear to have the epigenetic markers
of fully active ESs, even though they are not both stably tran-
scriptionally active. This is in agreement with results showing
that, if ES transcription is inducibly silenced, the ES chromatin
structure remains open for at least 24 h after induction of the
transcription block (37). During this period, there is transient
and reversible derepression of multiple silent ESs before com-
mitment to 1 ES by 48 h. In our double-expresser trypanosomes,
both unstably active ESs appear to have an epigenetic state that is
equivalent to that observed on fully active ESs. The fact that
trypanosomes released from drug-selection pressure invariably
relapsed back to either BES1 or BES2 at approximately equivalent
frequencies argues that establishing an active epigenetic state is an
essential first step for ES activation. However, the limiting step in
establishing monoallelic exclusion appears to be the ability of an
ES with the epigenetic marks of an active state to associate with or
nucleate an ESB, which can stably accommodate only a single ES.
Double-expresser trypanosomes are normally not observed in
wild-type populations, and the frequency of generation of these
T. brucei double-expresser strains was very low (<108) (26). It is
possible that these double-expresser strains have acquired genetic
mutations that facilitate their ability to become double-expressers.
We are currently investigating if double-expressers that have re-
lapsed back to single expression are more able to establish the
double-expresser phenotype compared with wild-type cells. If so,
this would argue that 1 or more heritable changes have facilitated
this disruption of monoallelic exclusion in our strains.
Nuclear architecture presumably plays a role in the monoallelic
exclusion observed at T. brucei ESs as well as in the monoallelic
exclusion operating at the var gene family of the malaria parasite
P. falciparum (6). Here, only 1 of 60 var genes is activated in a
mutually exclusive fashion, under the control of epigenetic factors
including histone modifications (53, 54). Location of var genes at
the nuclear periphery plays a key role in this control (55, 56). Both
silent and active var loci are located within different zones of the
nuclear periphery, whereby var activation requires escape from a
perinuclear repressive center to an area of the nuclear periphery
compatible with var gene activation (25). In contrast, in T. brucei,
the ESB is not located preferentially at the nuclear periphery and
does not obviously localize to one particular region of the nucleus.
However, it still remains to be seen if the active ES preferentially
interacts with other genomic regions within the nucleus.
Essential interchromosomal genomic interactions have been
documented in the monoallelic exclusion operating at the >1,000
different mammalian olfactory receptor genes expressed within
the sensory neurons of the nose (1). Here, large heterochromatic
domains sequester the silent olfactory receptor gene clusters
(57). However, within these inactive domains, interchromosomal
hubs between different olfactory receptor enhancers form, which
assemble over the 1 transcriptionally active olfactory receptor
gene (58). These clustered enhancers contribute to the formation
of olfactory receptor compartments, which then form a multi-
chromosomal superenhancer within the nucleus (5).
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No activating enhancer has yet been shown to play a role in
ES activation. Similarly, inactive ESs have not been shown to
obviously cluster within a single silencing compartment within
the nucleus. DNA FISH experiments detecting a characteristic
50-bp simple sequence repeat extending for tens of kilobases up-
stream of all known ES promoters (59) have indicated that these
are relatively dispersed within the nucleus (22, 60, 61). However,
more recent genome-wide chromosome conformation capture (Hi-C)
experiments have found that the VSGs at the silent ESs appear to
interact with each other at a higher than average frequency, arguing
that there is at least some clustering of these sequences within the
nucleus (52). These interchromosomal interactions could play a role
in control of ES transcription, as well as the DNA rearrangements at
the ES telomeres involved in VSG switching. However, it is still not
clear where the active ES is located within the context of these
different chromosomal compartments.
In summary, our results provide insights into the monoallelic
control of VSG expression in African trypanosomes. We show
that, if we perturb monoallelic exclusion in double-expresser cells,
we do not generate cells with additional ESBs. In contrast, we
generate a rapidly switching state, whereby nascent transcripts
from both ESs are only simultaneously observed within a 200-nm
compartment containing the ESB. This argues that the ESB
contains limiting factors for ES transcription and RNA processing,
and the restriction of these components to a single ESB facilitates
monoallelic exclusion. The 2 selected ESs appear to move in a
highly dynamic fashion within the nucleus and are in close prox-
imity to each other within the ESB only in the presence of si-
multaneous selection. These results highlight the importance of
the ESB structure in restricting monoallelic expression in T. brucei.
Methods
Generation of T. brucei Strains. Bloodstream-form (BF) T. brucei 427 was
cultured in vitro according to ref. 62, and the cell lines generated were derived
from the T. brucei “single marker” line (63). The VSG221 ES-targeting construct
(MK188) containing a puromycin/thymidine kinase (pur/TK) fusion gene and an
eGFP gene was inserted into the active VSG221 ES immediately upstream of
the telomeric VSG221 gene. The upstream target fragment of the MK188
construct contains 70-bp repeats from the VSG221 ES, and the downstream
fragment the VSG221 cotransposed region, as described in ref. 30.
These cells were cultured on puromycin selection (0.2 μgmL−1) to maintain
activation of the VSG221 ES, while thymidine kinase could be used as a
negative selectable marker. After validation, the cell line was removed from
puromycin selection for 48 h and subsequently diluted into media containing
ganciclovir (4 μg mL−1) and plated in 96-well plates. Clonal ganciclovir-resistant
cells were generated that had activated a different ES. The generated VSG
switch variants were screened by immunofluorescence microscopy for loss of
expression of GFP, and their protein lysates were analyzed byWestern blotting
to identify VSGV02 expressers. A VSGV02-expressing trypanosome clone was
identified, which was subsequently transfected with the VSGV02 ES-targeting
MK234 construct. This resulted in the integration of the hygromycin resistance
and mCherry genes immediately upstream of the telomeric VSGV02 gene. The
MK234 construct has an upstream target fragment containing the 70-bp re-
peat region from the VSGV02 ES and a downstream target fragment with the
VSGV02 cotransposed region. All primers used for construct assembly are listed
in SI Appendix, Table S1. PCR amplification of VSGV02 ES-containing se-
quences was performed by using TAR clones, which were described previously
(11, 64). This VSGV02-expressing cell line is referred to as T. brucei (V02+)PG-
VHC. The VSG221 ES was subsequently selected for in these cell lines, resulting
in its reactivation. This isogenic cell line is T. brucei (221+)PG-VHC.
Generation and Analysis of Double-Expresser T. brucei Cell Lines. The double-
expresser T. brucei (DE) KW01 cell line was generated by selecting the
VSG221-expressing (221+)PG-VHC line for resistance to both hygromycin
(50 μg mL−1) and puromycin (0.8 μg mL−1). The DE BH03 cell line was generated
by using the same approach, but using the VSGV02-expressing parental
(V02+)PG-VHC line. Frequency of generation of DE lines was low (<10−8). DE
cells lines were continuously maintained on double drug selection to
maintain double expression. DE lines were regularly validated by using flow
cytometry to monitor for simultaneous expression of the eGFP and mCherry
genes. In addition, immunofluorescence microscopy was used to confirm
expression of the appropriate VSG.
To simultaneously knock down eGFP and mCherry, a 405-bp fragment of
each gene was amplified and these were fused together. Sense and antisense
fragments of this fusionwere then inserted into the pLew100-V5x:Pex11 stem
loop construct (gift of Jay Bangs, University of Buffalo, Buffalo, NY) (65) by
using Gibson assembly. This fluorescent protein (FP) RNAi construct was
transfected into the T. brucei (221+)PG-VHC and DE KW01 cell lines, resulting in
the (221+)PG-VHC FP-RNAi and DE KW01 FP-RNAi cell lines. Tetracycline
induction of RNAi resulted in “defluorescing” the cells through simultaneous
knockdown of both eGFP and mCherry.
To epitope-tag the N terminus of the RNA polymerase I (Pol I) RPA2 subunit
(Tb927.11.630) with mNeonGreen, the coding sequence of mNeonGreen
(mNG) was amplified from the pPOTv4-blast-mNG plasmid (66) and was used
to replace eYFP in the pEnt5H-Y:NLS:RPA2 plasmid (both plasmids gift of the
laboratory of Keith Gull, University of Oxford, Oxford, UK) (67) by using
Gibson assembly. The hygromycin resistance gene was also replaced with a
blasticidin resistance gene. The resulting pEnt5B-mNG::RPA2 plasmid was
transfected into the (221+)PG FP-RNAi and DE KW01 FP-RNAi cell lines. For
VEX1 tagging, cells were transfected with the pNATVEX1x12myc construct
(gift of David Horn, University of Dundee, Dundee, UK).
To detect nascent transcription using RNA-FISH, a 24× MS2 repeat se-
quence obtained from Addgene (plasmid no. 27120) (68) was inserted into
the tubulin locus or BES2. To target the 24× MS2 sequence to the tubulin
locus, the pTub-Hyg-117-VSG3UTR construct (69) was modified such that the
Hyg-117 cassette was exchanged for the 24× MS2 sequence and the blasti-
cidin resistance gene. This pTub-24×MS2-blast construct was transfected into
the “single-marker” T. brucei cell line (63). For targeting MS2 repeats into
BES2, the hygromycin and mCherry genes in the MK234 construct were ex-
changed for a blasticidin gene and a 24× MS2 repeat array. This 70-bp
24×MS2-V02CTR construct was transfected into (V02+)PG-VHC or DE KW01
FP-RNAi cells. Integration of the MS2 repeat array into BES2 resulted in the
exchange of the hygromycin resistance and mCherry genes for the blastici-
din resistance gene and the 24× MS2 repeat array. Activation of BES2 was
then maintained by using selection on 20 μg−1 mL blasticidin. All primers
used for construct assembly are listed in SI Appendix, Table S1.
Growth curves were performed, monitoring for cell proliferation, by using
a Neubauer hemocytometer. Stability of the DE lines was monitored by re-
moving the lines from double drug selection. Here, T. brucei cells were
washed in prewarmed HMI-9 medium without drugs and resuspended in
media that did or did not contain the relevant selection drugs. Cells were
cultured, and flow cytometry analysis was performed as detailed later.
Flow Cytometry and Protein Analysis. T. brucei lines were fixed in 2% para-
formaldehyde for 20 min in the dark at room temperature. Cells probed with
anti-VSG antibodies were incubated in 0.5% BSA for 30 min and then incubated
with anti-VSG221(-CRD) antibody (Jay Bangs, University of Buffalo, Buffalo, NY)
or anti-VSGV02 antibody (Piet Borst, Netherlands Cancer Institute, Amsterdam,
The Netherlands) for 1 h. Cells were washed with PBS solution before 1-h in-
cubation with goat anti-rabbit IgG Alexa Fluor 647 secondary antibody. Cells
were washed in PBS solution and analyzed by using an LSRFortessa analyzer (BD
Bioscience) along with the appropriate compensation controls. Flow cytometry
data were analyzed by using FlowJo V10 software (FlowJo). Compensation was
applied by using the FlowJo software, and double-expresser cells were gated
using the 98th percentile of the relevant controls.
For the Western blot analyses, protein was extracted from 107 cells per cell
line, and 5 × 105 cell equivalents were loaded per lane. Gels were electro-
phoresed, blotted, and probed with anti-VSG221 antibody, anti-VSGV02
antibody, or anti-BiP (Jay Bangs, University of Buffalo, Buffalo, NY) by using
standard protocols.
Chromatin Immunoprecipitation. Chromatin immunoprecipitation (ChIP)
analysis of the distribution of histone H3, histone H1, and TDP1 was per-
formed as previously described in ref. 70, with minor modifications. Cells
were cross-linked with 1% formaldehyde for 1 h at room temperature.
Cross-linking was quenched by the addition of glycine to a final concen-
tration of 125 mM. Chromatin was sonicated (BioRuptor; Diagenode) to an
average DNA fragment size of 200 bp, and the extract was clarified by
centrifugation. Immunoprecipitation was performed for 18 h at 4 °C with
the relevant antibody or no antibody as a negative control. Antibodies used
were anti-histone H3 (Ab1791; Abcam), anti-histone H1 (described in ref. 30),
and anti-TDP (described in ref. 36) coupled to Dynabeads Protein G magnetic
beads (Novex; Life Technologies). ChIP experiments were performed in
triplicate, and the resulting material was analyzed by qPCR using the 7500
Fast Real-Time PCR system (Life Technologies). qPCR primers were previously
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described in refs. 28, 69, and 70 or are listed in SI Appendix, Table S2.
Quantitation of immunoprecipitated material was calculated as the per-
centage of input chromatin immunoprecipitated after subtraction of the
value for the no-antibody control.
J-IP seq experiments were performed following a protocol modified from a
previous work (35). Briefly, genomic DNA was sheared to ∼200 bp and
immunoprecipitated by using an antibody raised against base J (34). Li-
braries were prepared from the J-IP and corresponding pre-IP samples se-
quenced (PE75) on an Illumina HiSeq 4000 system, and reads aligned against
the T. brucei 427 reference genome (v36, with reconstructed BES1 and
BES2 sequences) using Bowtie2. Statistical significance of the ChIP data were
determined by using 2-way ANOVA with Tukey’s post hoc test and consid-
ered significant when P < 0.05 (SI Appendix, Table S5).
Microscopy and Image Analysis. For immunofluorescence microscopy, cells
were washed in 1× PSG buffer before fixing in a final concentration of 2%
paraformaldehyde (PFA) for 15 min. For VEX1 microscopy, VEX1::12myc-
tagged cells were permeabilized with 0.1% Nonidet P-40 for 5 min, fol-
lowed by 1 h blocking in 1% BSA. Slides were then incubated with an anti-myc
antibody (4A6; EMDMillipore), followed by incubation with a goat anti-mouse
secondary antibody. Fixed cells were mounted on slides by using Vectashield
containing the DNA stain DAPI. Microscopy was performed by using a Zeiss
Imager.M1 microscope equipped with a Zeiss AxioCam MRm camera and Axio
Vision Rel 4.8 software. Z-stacks were taken in 0.2-μm increments. For VSG
immunofluorescence microscopy, cells were fixed in 1% PFA for 10 min and
blocked in 1% BSA for 1 h. Cells were incubated with a mouse anti-VSG221
antibody (gift of Nina Papavasiliou, Deutsches Krebsforschungszentrum,
Heidelberg, Germany) and rabbit anti-VSGV02 antibody (gift of Piet Borst)
for 1 h, followed by incubation with goat anti-mouse DyLight488 antibody
and goat anti-rabbit DyLight594 antibody. Microscopy was performed
by using a Zeiss AxioImager M2 microscope with an ORCA Flash 4 camera
(Hamamatsu) and Zen software.
For superresolution structured illumination microscopy (SR-SIM), slides
were sealed with Zeiss high-performance coverslips and imaged by using a
Zeiss Elyra PS.1 with a sCMOS PCO Edge (SIM) camera using Zeiss Zen soft-
ware. For image acquisition, z-stacks were taken in 0.1-μm intervals with
5 phases and 3 rotations using 0.28-μm grid spacing. Structured illumination
reconstruction was performed by using Zen software, and SR-SIM data
quality was assessed by using SIM check. Chromatic aberrations were cor-
rected for by using 100-nm Tetraspeck beads (Thermo Fisher Scientific) with
the channel alignment function in Zen software for each SR-SIM experiment.
Channel alignment was determined in ImageJ for fluorescence microscopy.
Quantitation of the distances between FISH signals was performed by taking
a maximum-intensity projection of z-stacks and manually delineating a line
profile between each focus of interest by using ImageJ. The fluorescence
intensity output of each channel was then plotted, and the center of each
focus of interest (as determined by the pixel with the greatest intensity) was
used to determine the distance between them. Statistical analysis for mi-
croscopy data was performed by Student’s t test (paired, 2-tailed) unless
stated otherwise. Data were considered significant when P < 0.05.
FISH Experiments. FISH analysis performed on cell lines containing the FP-RNAi
construct was conducted at least 72 h after induction of RNAi by using 1 μgmL−1
tetracycline. For RNA FISH experiments, cells were fixed directly in medium
for 15 min using by paraformaldehyde at a final concentration of 4%. Cells
were washed in 1× PBS buffer and settled on microscopy slides (ThermoShandon)
for 30 min. Cells were then permeabilized by immersing slides in 70% ethanol
for 1 h in the presence of 25 U of RNase inhibitor (Roche). For combined RNA-
FISH with mNG::RPA2 imaging, cells were instead permeabilized with 0.1%
Nonidet P-40 for 5 min. Cells were then washed twice in 1× PBS solution and in
RNA wash buffer (10% formamide, 2× SSC) for 5 min each. For detection of
transcription from BES1, probe sets containing 40 Stellaris RNA-FISH probes of
20 nucleotides (nt; LGC Biosearch Technologies) were designed that were
complementary to a VSG pseudogene (Tb427.BES40.21) present within BES1.
These probe sets were conjugated to a C3-fluorescein dye or a Quasar-670 dye.
To detect transcription from the MS2 repeats, 3 different Stellaris RNA-FISH
probes (20 to 22 nt) were generated, which were complementary to the
MS2 repeats, and were conjugated to Quasar-570 dye. All RNA-FISH probe
sequences are listed in SI Appendix, Table S3.
Each probe was mixed to a final concentration of 125 nM in hybridization
buffer (10% dextran sulfate, 10% formamide, 2× SSC). The probe solution
was then preheated to 45 °C and added to samples, which were then sealed
with Gene Frames (Thermo Fisher Scientific) and hybridized at 45 °C over-
night in a hybridization oven. After hybridization, Gene Frames were re-
moved, and samples were washed for 30 min at 45 °C with preheated RNA
wash buffer. Slides were then washed for 5 min with 2× SSC and mounted
with VectaShield containing DAPI (Vector Laboratories). All buffers were
prepared using DEPC-treated water. Samples with combined RNA-FISH for
VSGΨ and MS2 with mNG::RPA2 imaging were imaged by using a Hama-
matsu ORCA-Flash4 with Zeiss Zen software. To measure half-lives of RNA-
FISH fluorescent signals, before PFA fixation, cells were treated with 2.5 μg mL−1
sinefungin (Millipore) for 5 min followed by incubation with 10 μg mL−1 acti-
nomycin D (Sigma) for 0.5, 1, 1.5, 2, 4, and 8 min. The percentage of cells with
VSGΨ and MS2 signal was then quantitated and plotted by using the 1-phase
exponential decay function in GraphPad.
For DNA FISH experiments, biotin- or digoxigenin-labeled DNA probes
were generated by PCR using standard conditions with Taq polymerase, with
the exception that a 1:2 ratio of biotin-16-dUTP (Sigma) or digoxigenin-11-
dUTP (Sigma) and dTTP were used in the reaction. Fourteen to sixteen
139- to 282-bp fragments specific for the relevant single-copy fluorescent
protein genes or drug resistance markers were amplified from plasmid DNA
used to generate the DE cell lines. Fragments from BES1 or BES2 were am-
plified from TAR clones (11, 64). Primers used to generate the DNA-FISH
probes are listed in SI Appendix, Table S4. All PCR fragments specific for
BES1 were labeled with digoxigenin, whereas all fragments specific for
BES2 were labeled with biotin. DNA probes were coprecipitated with salmon
sperm DNA (Invitrogen) at 10 μg mL−1 and yeast tRNA (Sigma) at 10 μg mL−1.
Probes were then resuspended to a concentration of 10 ng mL−1 in hy-
bridization buffer (50% formamide, 10% dextran sulfate, 2× SSC).
Before hybridization, cells were prepared in the same manner as for RNA-
FISH with the exception that permeabilization was performed with 0.1%
Nonidet P-40 for 10min followed by incubation with 50 μg mL−1 RNase (Sigma)
for 1 h at 37 °C. After adding probe mix to slides, samples were sealed with
Gene Frames and denatured on an inverted heat block at 85 °C for 5 min,
followed by overnight incubation at 37 °C. After hybridization, slides were
washed in DNA wash buffer (50% formamide, 2× SSC) for 30 min at 37 °C,
followed by three 10-min washes in 1× SSC, 2× SSC, and 4× SSC at 50 °C.
Samples were then incubated with an anti-digoxigenin antibody (Abcam 21H8)
diluted 1:10,000 in 1% BSA (wt/vol in 1× PBS solution) for 1 h at 37 °C. After
washing 3 times for 10min in TBS with 0.01% Tween, slides were incubated for
45 min with a streptavidin-Alexa Fluor 488 conjugate (Thermo Fisher Scientific)
and a goat anti-mouse Alexa Fluor secondary antibody (Thermo Fisher Scien-
tific), both diluted to 1:500 in 1% BSA. Samples were washed in TBS with
0.01% Tween as before and mounted in Vectashield with DAPI.
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